Cargando…

Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation

BACKGROUND: Mucopolysaccharidosis type IVA (MPS IVA) is an autosomal recessive disease caused by the deficiency of the lysosomal enzyme N-acetylgalactosamine-6-sulfate sulfatase (GALNS). The purpose of this study was to analyze the GALNS mutations and the haplotypes associated. METHODS: Mutation scr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chkioua, Latifa, Khedhiri, Souhir, Hafsi, Hind, Grissa, Oussama, Ben Turkia, Hadhami, Miled, Abdelhedi, Laradi, Sandrine, Froissart, Roseline, Alif, Najat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912732/
https://www.ncbi.nlm.nih.gov/pubmed/27317439
http://dx.doi.org/10.1186/s13000-016-0498-y
_version_ 1782438313656844288
author Chkioua, Latifa
Khedhiri, Souhir
Hafsi, Hind
Grissa, Oussama
Ben Turkia, Hadhami
Miled, Abdelhedi
Laradi, Sandrine
Froissart, Roseline
Alif, Najat
author_facet Chkioua, Latifa
Khedhiri, Souhir
Hafsi, Hind
Grissa, Oussama
Ben Turkia, Hadhami
Miled, Abdelhedi
Laradi, Sandrine
Froissart, Roseline
Alif, Najat
author_sort Chkioua, Latifa
collection PubMed
description BACKGROUND: Mucopolysaccharidosis type IVA (MPS IVA) is an autosomal recessive disease caused by the deficiency of the lysosomal enzyme N-acetylgalactosamine-6-sulfate sulfatase (GALNS). The purpose of this study was to analyze the GALNS mutations and the haplotypes associated. METHODS: Mutation screening of the GALNS gene was performed by direct sequence analysis using DNA samples from 15 unrelated Tunisian MPS IVA patients. We also analyzed the haplotypes associated with the novel mutation and with the other reported GALNS mutations. RESULTS: We have identified an unreported missense mutation p.D288G (c.863A > G) in one patient, the most frequently c.120 + 1G > A (IVS1 + 1G > A) mutation in eleven MPS IVA patients and three previously reported mutations p.G66R, p.A85T and p.R386C on the other MPS IVA patients. All the studied patients were homozygous for these identified mutations. Bioinformatics analysis predicted the novel mutation as being probably pathogenic. These findings with the unobserved p.D288G mutation in controls subjects, suggested that it is a disease-causing mutation, which was correlated with the severe phenotype observed in the patients. We have found that the two GALNS unreported and reported mutations, respectively p.D288G and p.R386C, were associated with a common and specific haplotype. CONCLUSION: Our results were in agreement with previous reports from Tunisia, suggesting, on one hand the genotype/phenotype correlations in MPS IVA patients and the other hand the haplotype analyses were useful for determination of mutation origin in Tunisian population.
format Online
Article
Text
id pubmed-4912732
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49127322016-06-19 Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation Chkioua, Latifa Khedhiri, Souhir Hafsi, Hind Grissa, Oussama Ben Turkia, Hadhami Miled, Abdelhedi Laradi, Sandrine Froissart, Roseline Alif, Najat Diagn Pathol Research BACKGROUND: Mucopolysaccharidosis type IVA (MPS IVA) is an autosomal recessive disease caused by the deficiency of the lysosomal enzyme N-acetylgalactosamine-6-sulfate sulfatase (GALNS). The purpose of this study was to analyze the GALNS mutations and the haplotypes associated. METHODS: Mutation screening of the GALNS gene was performed by direct sequence analysis using DNA samples from 15 unrelated Tunisian MPS IVA patients. We also analyzed the haplotypes associated with the novel mutation and with the other reported GALNS mutations. RESULTS: We have identified an unreported missense mutation p.D288G (c.863A > G) in one patient, the most frequently c.120 + 1G > A (IVS1 + 1G > A) mutation in eleven MPS IVA patients and three previously reported mutations p.G66R, p.A85T and p.R386C on the other MPS IVA patients. All the studied patients were homozygous for these identified mutations. Bioinformatics analysis predicted the novel mutation as being probably pathogenic. These findings with the unobserved p.D288G mutation in controls subjects, suggested that it is a disease-causing mutation, which was correlated with the severe phenotype observed in the patients. We have found that the two GALNS unreported and reported mutations, respectively p.D288G and p.R386C, were associated with a common and specific haplotype. CONCLUSION: Our results were in agreement with previous reports from Tunisia, suggesting, on one hand the genotype/phenotype correlations in MPS IVA patients and the other hand the haplotype analyses were useful for determination of mutation origin in Tunisian population. BioMed Central 2016-06-17 /pmc/articles/PMC4912732/ /pubmed/27317439 http://dx.doi.org/10.1186/s13000-016-0498-y Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Chkioua, Latifa
Khedhiri, Souhir
Hafsi, Hind
Grissa, Oussama
Ben Turkia, Hadhami
Miled, Abdelhedi
Laradi, Sandrine
Froissart, Roseline
Alif, Najat
Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation
title Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation
title_full Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation
title_fullStr Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation
title_full_unstemmed Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation
title_short Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation
title_sort molecular analysis in a galns study cohort of 15 tunisian patients: description of a novel mutation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912732/
https://www.ncbi.nlm.nih.gov/pubmed/27317439
http://dx.doi.org/10.1186/s13000-016-0498-y
work_keys_str_mv AT chkioualatifa molecularanalysisinagalnsstudycohortof15tunisianpatientsdescriptionofanovelmutation
AT khedhirisouhir molecularanalysisinagalnsstudycohortof15tunisianpatientsdescriptionofanovelmutation
AT hafsihind molecularanalysisinagalnsstudycohortof15tunisianpatientsdescriptionofanovelmutation
AT grissaoussama molecularanalysisinagalnsstudycohortof15tunisianpatientsdescriptionofanovelmutation
AT benturkiahadhami molecularanalysisinagalnsstudycohortof15tunisianpatientsdescriptionofanovelmutation
AT miledabdelhedi molecularanalysisinagalnsstudycohortof15tunisianpatientsdescriptionofanovelmutation
AT laradisandrine molecularanalysisinagalnsstudycohortof15tunisianpatientsdescriptionofanovelmutation
AT froissartroseline molecularanalysisinagalnsstudycohortof15tunisianpatientsdescriptionofanovelmutation
AT alifnajat molecularanalysisinagalnsstudycohortof15tunisianpatientsdescriptionofanovelmutation